kabutan

Techno Medica Co., Ltd., First Half Ordinary Profit Decreases by 44%, July-September Ordinary Profit Decreases by 90%

Thu Nov 7, 2024 3:30 pm JST Earnings

6678 Techno Medica Co., Ltd. 【J-GAAP】

Earnings Report

Techno Medica Co., Ltd. <6678> [TSE-S] announced its financial results after the market closed on November 7th (15:30). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) dropped by 44.1% from the same period last year to 298 million yen. The progress rate against the 1.4 billion yen full-year plan was 21.3%, also falling below the five-year average of 33.1%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to decrease by 17.6% from the same period last year to 1.1 billion yen.

In the most recent three-month period, from July to September (2Q), the ordinary profit significantly dropped to 43 million yen, a 90.3% decrease compared to the same period last year. The operating profit margin sharply declined from 19.3% in the same period last year to 2.6%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 3,772 446 454 309 36.7 27.2 Nov 4, 2022 J-GAAP
Apr - Sep, 2023 4,056 523 533 376 46.2 28.5 Nov 7, 2023 J-GAAP
Apr - Sep, 2024 4,116 304 298 221 32.1 21.3 Nov 7, 2024 J-GAAP
YoY +1.5% -41.9% -44.1% -41.2% -30.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance 4,300 350 350 240 34.6 0 May 9, 2024 J-GAAP
Apr - Sep, 2024 Results 4,116 304 298 221 32.1 0 Nov 7, 2024 J-GAAP
Revision Rate -4.3% -13.1% -14.9% -7.9% -7.4%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 6,227 1,317 1,337 972 124.7 68 May 9, 2024 J-GAAP
Oct - Mar, 2024 Guidance 5,884 1,096 1,102 749 108.1 68 Nov 7, 2024 J-GAAP
YoY -5.5% -16.8% -17.6% -22.9% -13.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 9,367 1,649 1,668 1,150 136.4 60 May 10, 2023 J-GAAP
Mar, 2024 10,283 1,840 1,870 1,348 173.0 68 May 9, 2024 J-GAAP
Mar, 2025 Guidance 10,000 1,400 1,400 970 140.0 68 May 9, 2024 J-GAAP
YoY -2.8% -23.9% -25.1% -28.0% -19.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 2,286 442 442 304 37.3 19.3 Nov 7, 2023 J-GAAP
Oct - Dec, 2023 2,368 405 404 270 33.5 17.1 Feb 7, 2024 J-GAAP
Jan - Mar, 2024 3,859 912 933 702 90.1 23.6 May 9, 2024 J-GAAP
Apr - Jun, 2024 1,999 250 255 173 25.1 12.5 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 2,117 54 43 48 7.0 2.6 Nov 7, 2024 J-GAAP
YoY -7.4% -87.8% -90.3% -84.2% -81.4%

Related Articles